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ABSTRACT 
Group-based latent trajectory modeling (GBLTM) is a relatively recent addition to 
methodology for analyzing repeated measures of a variable over time. It is implemented using 
SAS procedure TRAJ for a zero-inflated Poisson (ZIP) model, censored normal (CNORM) 
model, and logistic model. Cross-validation (CV) in GBLTM is used as an alternative tool to the 
Bayesian Information Criterion (BIC) for determining the optimal number of distinct latent 
subgroups in a sample. CV in GBLTM when assuming a ZIP model is implemented using the 
crimCV package in R. In this thesis, the use of CV in GBLTM is furthered by applying it when 
assuming a CNORM model and examining the consistency of results when considering multiple 
types of CV. This method is applied to a Hepatitis C (HCV) study to determine whether patterns 
of depressive symptoms in HCV patients treated with interferon-based therapy form clinically 
meaningful distinct subgroups. When applied to the HCV study, CV was a conservative 
approach to model selection compared with BIC; CV suggested a two-group model, whereas 
BIC suggested a five-group model. However, when visually examining the data, a three-group 
model appeared to capture the heterogeneity in the HCV sample best. Therefore, BIC and CV 
should not be used alone to determine the optimal number of distinct latent subgroups in a 
sample, but rather used to make an educated judgment on the number of subgroups that describes 
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the heterogeneity best. Whether or not CV is truly a conservative approach to model selection 
compared with BIC is still unknown, CV and BIC should be further explored using other datasets 
and simulations. The public health significance of this thesis is exploring statistical tools used for 
determining the optimal number of distinct latent subgroups in GBLTM, where knowledge of the 
factors that predispose individuals to less favorable trajectory groups, can lead to targeted 
preventions. 
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1.0  INTRODUCTION 
1.1 OVERVIEW 
Group-based latent trajectory modeling (GBLTM) is a relatively new addition to the 
methodology of analyzing longitudinal data. GBLTM is useful when one is interested in 
determining whether there exist distinct subgroups in a sample, where each subgroup consists of 
individuals who share similar patterns of repeated measures over time. The Bayesian Information 
Criterion (BIC) is used for model selection in GBLTM to determine the optimal number of 
distinct subgroups existing in a sample. However, BIC sometimes suggests an unreasonable 
amount of subgroups [1-6]. 
Cross-validation (CV) is a statistical method of evaluating and comparing different 
models by dividing available data into two sets used for constructing a model and to validate the 
model that was constructed [7]. CV can be used to estimate the generalizability of a model's 
performance and is thus an alternative to BIC for model selection. CV is implemented in 
GBLTM for determining the optimal number of latent subgroups in a zero-inflated Poisson (ZIP) 
model using an R package, crimCV [8]. 
In this thesis, the use of CV in GBLTM was furthered by applying it when assuming a 
censored normal (CNORM) model. Different types of CV were examined to determine if each 
type suggests a consistent number of latent subgroups and how they compare with BIC. We used 
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CV in GBLTM to evaluate longitudinal data from a hepatitis C (HCV) study, with the aim of 
determining the number of clinically meaningful distinct subgroups of patients who share similar 
patterns of change in depressive symptoms over the course of treatment. 
1.2 GROUP-BASED LATENT TRAJECTORY MODELING (GBLTM) 
There are three main branches of group-based methodology used to analyze repeated measures 
of a variable over time, one of them being group-based latent trajectory modeling (GBLTM) [9]. 
The others are hierarchical modeling [10-12] and growth curve analysis [13-16]. All three 
methodologies strive to model individual-level heterogeneity in longitudinal data. Hierarchical 
modeling uses the strategy of a random coefficient model to capture individual variation in 
repeated measures over time, whereas growth curve analysis uses the method of a covariance 
structure. Both of these methods assume the parameters of a trajectory follow the same 
distribution, meaning the population distribution of trajectories varies across individuals 
continuously and can be modeled in most cases using a multivariate normal distribution [9]. 
GBLTM takes a different approach by using a semiparametric multinomial modeling technique, 
making the assumption that there are distinct groups of trajectories that exist due to underlying 
latent traits. A latent trait is an unobservable variable that is thought to cause a pattern in 
observed variables. GBLTM was created to compliment hierarchical modeling and growth curve 
analysis [17]. Note that, while we focus specifically on the strategy implemented using SAS 
TRAJ procedure (Proc TRAJ), GBLTM can also be employed in a Structural Equation Modeling 
(SEM) framework. 
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GBLTM partitions a cohort into subgroups based on repeated measures of a variable over 
time and baseline risk factors [17-19]. This enables one to classify individuals based on latent 
traits that can change over time. Nagin and Land first introduced the concept in their 1993 
manuscript entitled “Age, Criminal Careers, and Population Heterogeneity: Specification and 
Estimation of a Nonparametric, Mixed Poisson Model”, where they used a semiparametric 
estimation procedure in order to identify distinct groups of criminals who shared similar patterns 
of offending over time [20]. In 1996 Land, McCall, and Nagin furthered the mixture model 
approach [21] and in 1999 Roeder, Lynch, and Nagin were able to allow for the uncertainty of 
latent class membership, as well as incorporate time stable covariates [19]. The statistical theory 
continued to develop [6, 22] and in 2001, Jones, Nagin, and Roeder created Proc TRAJ to 
implement GBLTM for three different models: ZIP model, CNORM model, and logistic 
(LOGIT) model [17]. 
GBLTM is a data-driven procedure that describes the heterogeneity existing in 
populations that may be difficult to identify a priori. An advantage of this technique is that rather 
than examining the population-average change, distinct subgroups are identified empirically, 
where each subgroup consists of subjects who share similar patterns of repeated measures over 
time. In addition, risk factors can then be examined to explore whether demographic and clinical 
variables of interest measured at baseline are associated with specific subgroups. 
A model selection process using BIC is already well established in GBLTM [19, 23], 
where the first step is determining the optimal number of distinct subgroups using BIC. BIC [24] 
is a statistical tool used to evaluate model fit, which is based on the log-likelihood evaluated at 
the maximum likelihood estimate (MLE) with an additional penalty term for the number of 
parameters added. The model with the number of latent subgroups that maximizes the BIC 
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should be chosen, as long as the difference in BIC between the next best model is meaningful. 
The log Bayes factor approximation is a useful tool for determining a meaningful difference in 
BIC. It is classified into four groups, as the amount of evidence against a simpler model: “Not 
worth mentioning”, “Positive”, “Strong”, and “Very Strong”. Unfortunately, programs such as 
Proc TRAJ and Mplus sometimes compute a BIC that suggests an unreasonable amount of 
groups [8], where the model will contain a redundant group and/or a group consisting of less 
than 5% of the sample [1-6]. 
1.3 CROSS-VALIDATION (CV) 
Cross-validation (CV) is a statistical method that can be used in model selection. CV evaluates 
and compares different models by dividing available data into two sets, which are used for 
constructing a model (training set) and validating the model (validation set) [7]. Statistical 
analyses often aim to learn a model from available data, but this may be difficult because the 
model may demonstrate adequate prediction capability on the available data but fail to predict 
future unseen data. To address this issue, CV is a method which estimates the generalizability of 
a model's performance. The idea of CV originated in 1931 [25], and the idea of CV that is 
similar to today's k-fold CV was introduced in 1968 [26]. 
In 2011, Nielsen et al. proposed CV as an alternative to BIC for determining the number 
of latent subgroups in GBLTM when assuming a zero-inflated Poisson (ZIP) model [8]. They 
implement leave-one-out CV (LOOCV) in R package crimCV for determining the optimal 
number of latent subgroups in a ZIP model [8]. LOOCV is also known as n-fold CV and 
jackknife resampling. Other types of CV include re-substitution validation, hold-out validation, 
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k-fold CV, and repeated k-fold CV. This thesis focuses on five-fold CV, five by two-fold, and 
LOOCV. 
1.4 CURRENT PROJECT 
As discussed above, latent traits that are thought to cause patterns in repeated measures over time 
may be difficult to identify a priori. When using population-average techniques in trajectory 
modeling (such as hierarchal models and growth curve analysis), it is often unclear whether an 
association found represents an overall trend or if it is driven by a specific subgroup of the 
sample. GBLTM makes it possible to explore whether such associations are in fact driven by a 
specific subgroup. Knowledge of factors that predispose individuals to less favorable trajectories, 
can lead to targeted prevention. For this thesis, multiple types of CV are applied to GBLTM 
when assuming a censored normal model. A SAS macro is developed to apply CV in GBLTM 
while using Proc TRAJ. Therefore the novel aspect presented here are: (1) use of CV in GBLTM 
for CNORM models as an alternative to BIC in model selection, (2) comparison of the models’ 
consistency using multiple types of CV, and (3) interpreting the differences between model 
selection criteria. 
This method is applied to a hepatitis C (HCV) study, to determine how many distinct 
subgroups of change in depressive symptoms exist during the course of interferon-based therapy. 
The optimal number of latent groups in the HCV study was first selected using BIC and again 
using multiple types of CV.  
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1.5 PUBLIC HEALTH SIGNIFICANCE 
GBLTM is a statistical tool that enables one to classify the across-patient heterogeneity to get a 
better picture of the prognosis of different latent subgroups that exist within the population. 
Population average techniques, such as mixed models which pre-specify subgroups, are not 
always an effective tool to use when dealing with highly diverse patient populations because they 
assume that each fixed population follows the same distribution. GBLTM allows for each latent 
subgroup to follow a different distribution, making it possible to sort through longitudinal 
heterogeneity in a sample to allow for more person centered models. With a growing interest for 
personalized medicine, it is likely that GBLTM will continue to become increasingly popular. 
 There is a need for a more rigorous method for determining the true number of latent 
subgroups in a population. This thesis contributes to public health research by exploring different 
statistical tools used for determining the optimal number of latent subgroups in GBLTM. We test 
how CV may serve as an alternative tool to BIC for model selection in GBLTM. It is important 
to be able to find the best, most parsimonious model so that the number of latent subgroups fully 
describes the underlying heterogeneity in a population. Once the optimal number of groups is 
found, associations between baseline risk factors and group membership can be examined in 
order to discover why some subjects experience less favorable trajectories compared to others, or 
what causes subjects who are assigned to a group with a favorable trajectory to be so resilient 
throughout a study. It is important to be able to identify the number of latent subgroups based on 
an objective criterion, to support well informed targeted prevention techniques. 
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2.0  STATISTICAL METHODS 
2.1 ESTIMATION OF GROUP-BASED TRAJECTORIES 
A brief overview of the theory behind GBLTM is given, however much more detail can be found 
elsewhere [6, 19-22]. 
Let 𝑌𝑌𝑖𝑖𝑖𝑖 be the longitudinal outcome of interest for the 𝑖𝑖𝑡𝑡ℎ subject at the 𝑗𝑗𝑡𝑡ℎ time point, 
where 𝑖𝑖 = 1, … ,𝑁𝑁 subjects and 𝑗𝑗 = 1, … , 𝐽𝐽𝑖𝑖 time points. Let 𝑘𝑘 = 2, … ,𝐾𝐾 be the number of latent 
subgroups that exists in a population, where each subgroup consists of subjects who share similar 
measurements of the outcome over time. Let 𝐶𝐶𝑖𝑖 be the unobservable latent variable of the 𝑖𝑖𝑡𝑡ℎ 
subject, where the latent variable is assumed to be the underlying reason to why a subject 
experienced a certain pattern in repeated measures of the outcome over time. Let 𝑧𝑧𝑖𝑖 denote the 
𝑖𝑖𝑡𝑡ℎ subject's measurements for time-stable covariates, also known as baseline risk factors. The 
model is then developed as a standard finite mixture model with k-components constructed using 
the following marginal density function: 
𝑓𝑓�𝑦𝑦𝑖𝑖𝑖𝑖� = �𝑃𝑃𝑃𝑃(𝐶𝐶𝑖𝑖 = 𝑘𝑘|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖)𝑃𝑃𝑃𝑃�𝑌𝑌𝑖𝑖𝑖𝑖 = 𝑦𝑦𝑖𝑖𝑖𝑖|𝐶𝐶𝑖𝑖 = 𝑘𝑘�𝐾𝐾
𝑘𝑘=1
, 
where 𝑃𝑃𝑃𝑃(𝐶𝐶𝑖𝑖 = 𝑘𝑘|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖) is the posterior probability of belonging to group k given measured 
baseline risk factors and 𝑃𝑃𝑃𝑃�𝑌𝑌𝑖𝑖𝑖𝑖 = 𝑦𝑦𝑖𝑖𝑖𝑖|𝐶𝐶𝑖𝑖 = 𝑘𝑘� is the probability of repeated measures of the 
outcome of interest over time given a subject belongs to the 
 
k th  latent subgroup of a population. 
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 The posterior probability is modeled as a K-outcome logit function using multinomial 
logistic regression to illustrate the relationship between baseline risk factors and k latent 
subgroups. The posterior probability of belonging to the 𝑘𝑘𝑡𝑡ℎ group given certain baseline risk 
factors is calculated based off of Bayes' Theorem using the following equation: 
𝜋𝜋𝑖𝑖
𝑘𝑘 = 𝑃𝑃𝑃𝑃(𝐶𝐶𝑖𝑖 = 𝑘𝑘|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖) = 𝑒𝑒𝑒𝑒𝑒𝑒{𝜃𝜃𝑘𝑘 + 𝛾𝛾𝑘𝑘′ 𝑧𝑧𝑖𝑖}∑ 𝑒𝑒𝑒𝑒𝑒𝑒{𝜃𝜃𝑙𝑙 + 𝛾𝛾𝑙𝑙′𝑧𝑧𝑖𝑖}𝐾𝐾𝑙𝑙=1 , 
Where 𝜃𝜃 = (𝜃𝜃1, … ,𝜃𝜃𝑘𝑘) is the group effect and 𝛾𝛾 = (𝛾𝛾1, … , 𝛾𝛾𝑘𝑘) is the additional group effect 
given baseline risk factors. The title posterior probability was given because these probabilities 
are computed after fitting a model, using the model's estimated coefficients [23].  
 The main focus of GBLTM is to learn about the relationship between baseline risk factors 
and latent subgroups, but to do this longitudinal data, 𝑌𝑌𝑖𝑖𝑖𝑖, has to be used in order to understand 
the unobservable latent trait involved in group membership [19]. There are three different models 
developed in Proc TRAJ to model the probability of observing a certain pattern in repeated 
measures of the outcome over time given the subject belongs to the 𝑘𝑘𝑡𝑡ℎ latent subgroup: ZIP 
model, CNORM model, and LOGIT model. This thesis will focus on the CNORM model. 
 The CNORM model is particularly useful for psychometric scale data, which addresses 
the problem of clustering at the minimum and maximum of the scale, also known as floor and 
ceiling effect. A ceiling effect is when a subject starts off with very high symptoms and cannot 
get a measurement much higher than that at their next follow-up visit because they were already 
near the maximum of the scale to start off with. Therefore, the rate of change of the individual’s 
trajectory may not be an accurate representation of their true change in symptoms. A floor effect 
is the same idea, except a subject is experiencing no symptoms, so their symptom count cannot 
decrease any more. A distribution that allows for censoring at the minimum and maximum of a 
scale addresses this issue of subjects clustering at low or high symptoms [17]. The likelihood of 
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observing a specific pattern of repeated measures over time in subject 𝑖𝑖 when they belong to 
latent subgroup 𝑘𝑘 is: 
𝑃𝑃𝑃𝑃�𝑌𝑌𝑖𝑖𝑖𝑖 = 𝑦𝑦𝑖𝑖𝑖𝑖|𝐶𝐶𝑖𝑖 = 𝑘𝑘�
= � Φ�𝑀𝑀𝑖𝑖𝑀𝑀 − 𝜇𝜇𝑖𝑖𝑖𝑖𝑘𝑘
𝜎𝜎
�
𝑦𝑦𝑖𝑖𝑖𝑖=𝑀𝑀𝑖𝑖𝑀𝑀
� ϕ�
𝑦𝑦𝑖𝑖𝑖𝑖 − 𝜇𝜇𝑖𝑖𝑖𝑖𝑘𝑘
𝜎𝜎
�
𝑀𝑀𝑖𝑖𝑀𝑀<𝑦𝑦𝑖𝑖𝑖𝑖<𝑀𝑀𝑀𝑀𝑀𝑀
� 1 −Φ�𝑀𝑀𝑀𝑀𝑒𝑒 − 𝜇𝜇𝑖𝑖𝑖𝑖𝑘𝑘
𝜎𝜎
�
𝑦𝑦𝑖𝑖𝑖𝑖=𝑀𝑀𝑀𝑀𝑀𝑀
, 
where 𝜇𝜇𝑖𝑖𝑖𝑖𝑘𝑘 = 𝛽𝛽0𝑘𝑘 + 𝛽𝛽1𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖 + 𝛽𝛽2𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖2 + ⋯+ 𝛽𝛽𝑝𝑝𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖𝑝𝑝 + 𝜆𝜆𝑤𝑤𝑖𝑖𝑖𝑖. The polynomial degree 
for each trajectory is denoted as 𝑒𝑒, where if 𝜇𝜇 consists of 
 
p = 0,1,2 then the trajectory is a 
second-degree polynomial, also known as a quadratic curve. Along with time-stable covariates, 
GBLTM can also incorporate time-varying covariates; the measurement of time-varying 
covariates for the 𝑖𝑖𝑡𝑡ℎ subject at the 𝑗𝑗𝑡𝑡ℎ time point is denoted as 𝑤𝑤𝑖𝑖𝑖𝑖 and 𝜆𝜆 is the effect of the time-
varying covariate on trajectory mean. This thesis focuses only on time-stable covariates and we 
consider up to a second-degree polynomial, which reduces the expected trajectory for the 𝑖𝑖𝑡𝑡ℎ 
subject in the 𝑘𝑘𝑡𝑡ℎ latent subgroup to 𝜇𝜇𝑖𝑖𝑖𝑖𝑘𝑘 = 𝛽𝛽0𝑘𝑘 + 𝛽𝛽1𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖 + 𝛽𝛽2𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖2 . 
2.1.1 Computing the Bayesian Information Criterion (BIC) 
BIC is recommended for model selection in many different methods of modeling. This  includes, 
determining the number of groups underlying the method of GBLTM [23]. BIC is a tool similar 
to the likelihood ratio test; however BIC can be used with models that are not nested. BIC also 
has the advantage of a penalty term for extra parameters added. The main reason BIC is used in 
GBLTM instead of the likelihood ratio test is because the null hypothesis of choosing a smaller 
number of groups versus the alternative hypothesis of a larger number of groups is on the 
boundary of the parameter space. When this occurs, standard asymptotic results [27] no longer 
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hold, and hence the change in BIC [28] is used instead. When this issue is ignored, the likelihood 
ratio test tends to favor the alternative hypothesis of a more complex model [29]. 
BIC is calculated for each model by summing two portions: one involving the likelihood 
and the other involving a penalty term for the number of parameters added to the model: 
𝐵𝐵𝐵𝐵𝐶𝐶 = 𝑙𝑙𝑙𝑙𝑙𝑙�𝐿𝐿�𝜃𝜃��� + 0.5𝑞𝑞𝑙𝑙𝑙𝑙𝑙𝑙(𝑀𝑀). 
The log-likelihood evaluated at the MLE is denoted as 𝑙𝑙𝑙𝑙𝑙𝑙�𝐿𝐿�𝜃𝜃���. This portion of the BIC 
equation continues to improve as the number of latent subgroups increases. This term is similar 
to 𝑅𝑅2 in linear regression because 𝑅𝑅2 can only increase with the addition of another parameter 
[23]. However, the second half of the BIC equation counterbalances this effect, where 𝑞𝑞 is the 
number of parameters added to the model and 𝑀𝑀 is the sample size. The polynomial degree of 
each trajectory and the number of latent subgroups both contribute to the number of parameters 
in a model. 
When comparing two models in GBLTM, the model with the largest BIC is chosen as 
long as the difference in BIC between the two models is meaningful. The Bayes factor is a useful 
statistic for determining whether the difference between BIC from two models is meaningful. It 
measures the posterior odds of the more complex model being the correct model for the available 
data compared to the simpler model [23]: 
𝐵𝐵𝑀𝑀𝑦𝑦𝑒𝑒𝐵𝐵 𝐹𝐹𝑀𝑀𝐹𝐹𝑡𝑡𝑙𝑙𝑃𝑃 = 𝑃𝑃𝑃𝑃(𝐶𝐶𝑙𝑙𝑡𝑡𝑒𝑒𝑙𝑙𝑒𝑒𝑒𝑒 𝑀𝑀𝑙𝑙𝑀𝑀𝑒𝑒𝑙𝑙 𝑖𝑖𝐵𝐵 𝐶𝐶𝑙𝑙𝑃𝑃𝑃𝑃𝑒𝑒𝐹𝐹𝑡𝑡)
𝑃𝑃𝑃𝑃(𝑆𝑆𝑖𝑖𝑡𝑡𝑒𝑒𝑙𝑙𝑒𝑒𝑃𝑃 𝑀𝑀𝑙𝑙𝑀𝑀𝑒𝑒𝑙𝑙 𝑖𝑖𝐵𝐵 𝐶𝐶𝑙𝑙𝑃𝑃𝑃𝑃𝑒𝑒𝐹𝐹𝑡𝑡) . 
A Bayes factor of five is interpreted as the simpler model is five times more likely than the 
complex model, which is noted as moderate evidence for the simpler model [30]. However, 
calculating the Bayes factor is very difficult. In GBLTM, this is avoided by using the log Bayes 
factor approximation [9, 17]: 2 log𝑒𝑒(𝐵𝐵10) ≈ 2(ΔBIC). 
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The approximation is simply twice the change in BIC, where the change is the BIC from the 
more complex model minus the BIC from the simpler model: 
ΔBIC = BICcomplex 𝑚𝑚𝑚𝑚𝑚𝑚𝑒𝑒𝑙𝑙 − 𝐵𝐵𝐵𝐵𝐶𝐶𝑆𝑆𝑖𝑖𝑚𝑚𝑝𝑝𝑙𝑙𝑒𝑒𝑆𝑆 𝑚𝑚𝑚𝑚𝑚𝑚𝑒𝑒𝑙𝑙. 
The log Bayes factor approximation is a way to explain the amount of evidence supporting a 
more complex model and is thus an easier way to assess whether the change in BIC between two 
models is meaningful. The amount of evidence against the null hypothesis of a simpler model 
can be categorized into four groups: “Not worth mentioning”, “Positive”, “Strong”, and “Very 
Strong” evidence against a simpler model (Table 1). This allows one to easily determine a 
meaningful change [17]. 
 
Table 1. Guideline of a meaningful change in BIC 
Log Bayes factor approximation: 2(Δ𝐵𝐵𝐵𝐵𝐶𝐶) Evidence against the null hypothesis:  H0: simpler model (smaller number of groups) 
<2 Not worth mentioning 
2 to <6 Positive 
6 to <10 Strong 
≥10 Very strong 
Note: adapted from [17] 
2.1.2 Issues with BIC in GBLTM 
The MLEs involved in GBLTM cannot be derived because their respective equations are not in 
closed-form. Therefore, Proc TRAJ uses EM algorithm to search for the parameter estimate that 
maximizes the likelihood [23]. Even when the EM algorithm successfully finds the correct 
MLEs, the BIC may still suggest an unreasonable amount of groups [1-6, 8]. In some situations, 
the BIC continues to increase as the number of groups increases [9], when the additional groups 
do not represent clinically distinct, valid subgroups. Different guidelines are often employed, 
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such as no group should consist of less than 5% of the sample, the average group posterior 
probability has to be at least 0.70, the groups have to make “clinical sense”, and subject-specific 
judgments [2, 31]. 
2.2 METHODS OF CROSS-VALIDATION (CV) 
2.2.1 K-Fold CV 
K-fold CV is the basic form of CV, where other types are special forms of k-fold CV [7]. In k-
fold CV the data is partitioned into k equally sized sets and k-iterations of training and validation 
are performed, where during each iteration a different set is excluded from modeling and the rest 
of the sets are combined to construct the model. The set that was excluded is then used to 
validate the constructed model. The most widely used versions of k-fold CV are five-fold and 
ten-fold. In order to fully understand k-fold CV, five-fold CV will be explained in more detail. 
In five-fold CV the data is split into five roughly equal sets (Figure 1). The first step is to 
exclude one set and construct a model by combining the four other sets. In Figure 1, we first 
exclude the fifth set and combine sets one, two, three, and four to construct a model. Once the 
best-fit model is constructed for these four sets, set five is used to validate the constructed model. 
The information from the constructed model, will be used to predict the outcome of subjects in 
set five. Because the true values for these subjects’ outcome are actually known, an estimate of 
how well the model is performing on the fifth set can be determined by calculating the absolute 
deviation between the actual values and the predicted values: 
𝐴𝐴𝐷𝐷5,𝑖𝑖 = �𝑦𝑦𝑖𝑖 − 𝑦𝑦�𝑖𝑖[−5]�. 
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Here 𝐴𝐴𝐷𝐷5,𝑖𝑖 is the estimated error of the 𝑖𝑖𝑡𝑡ℎ subject who was randomly assigned to the fifth set, 
where 𝑖𝑖 = 1, … ,𝑀𝑀5. The actual value for the 𝑖𝑖𝑡𝑡ℎ subject’s outcome is denoted as 𝑦𝑦𝑖𝑖 and the 
predicted value of their outcome from the model that was constructed while excluding the fifth 
set is 𝑦𝑦�𝑖𝑖
[−5]. The absolute deviation is calculated for every subject in the fifth set and a mean 
absolute deviation is found by averaging across all of the subjects in the fifth set: 
𝐴𝐴𝐷𝐷5 = 1𝑀𝑀5�𝐴𝐴𝐷𝐷5,𝑖𝑖𝑀𝑀5
𝑖𝑖=1
. 
This gives the user an idea of how well their training model predicts future unseen data. This 
procedure is repeated four more times, each time excluding a different set of the data to use for 
validation and using the remaining 80% of the data for the training model (Figure 1). Once all 
calculations are completed for every set, an overall mean absolute deviation can be calculated by 
taking the grand mean of the average absolute deviations from each set of the data: 
𝐴𝐴𝐷𝐷 = 15 �𝐴𝐴𝐷𝐷𝑤𝑤5
𝑤𝑤=1
, 
where 𝐴𝐴𝐷𝐷𝑤𝑤 denotes the absolute deviation from the 𝑤𝑤𝑡𝑡ℎ set (𝑤𝑤 = 1, … , 𝑀𝑀𝑤𝑤).  
There exist others ways of measuring the model fit in CV for continuous data including, 
median absolute deviation, mean squared error, paired t-test, and more [8, 32]. This paper 
focuses on mean absolute deviation. 
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 Figure 1. Illustration of five-fold Cross-validation Process 
 
2.2.2 Repeated K-fold Cross-validation 
Repeated k-fold CV is the process of performing k-fold CV multiple times, where each time the 
data is reshuffled and re-stratified before each round. A commonly used version of repeated k-
fold CV is five by two-fold CV [7]. In five by two-fold CV, available data is split up into two 
non-overlapping sets. The first set is held out and the second set is used to construct a model. 
Once the best-fit model is constructed, the first set is used to validate the constructed model. The 
AD between actual and predicted values of the outcome is calculated and this process is 
repeated, by constructing a model with the first set and validating the constructed model with the 
second set instead. Once this process is complete, the data is randomly split into two different 
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groups and the process of training and validating is repeated on the two newly stratified groups. 
This is repeated three more times, each time randomly splitting the data up into two new groups.  
The process of five by two-fold CV differs from five-fold CV in two ways: (1) the data is 
split into two groups instead of five and (2) once the process of two-fold CV is performed the 
data is re-stratified into two different groups and the process is repeated, so that there are five 
iterations of two-fold CV. An advantage of repeated k-fold CV is that the number of estimates 
has increased, smoothing the estimates, but a disadvantage is that an unreliably low estimate for 
the variance is given. Another disadvantage is that the training and testing data are now 
overlapping between each round of k-fold CV, as well as the training data is overlapped within 
each round of k-fold CV [7]. 
2.2.3 Leave one out Cross-validation (LOOCV) 
LOOCV (also known as n-fold CV or Jackknife resampling) is a special case of k-fold CV, 
where k is the number of subjects in the available data. The process of LOOCV is first excluding 
one subject from the dataset, and then constructing a model using the remaining N-1 subjects. 
Once the best-fit model is constructed, the model is tested on the single subject that was 
excluded. This process is repeated for every subject in the data set. An advantage of this method 
of CV is that it results in unbiased estimates of the generalizability of a model's performance and 
disadvantages are it results in a very large variance of the performance estimate, since the 
estimate was based on a single subject and the process is computationally intensive for large 
datasets [7]. 
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2.2.4 How CV is implemented in GBLTM for a censored normal model 
SAS Proc TRAJ easily enables the addition of CV to GBLTM. An example of how this is done 
will be illustrated again using five-fold CV. Once the data is split into five roughly equal sets, the 
first step (Figure 1) is to combine sets one, two, three, and four to construct a training model, 
while setting set five aside for validation. Proc TRAJ will be used to construct the best-fit 
training model for the available data in sets one through four. Once the best-fit model is found, 
the MLE for each parameter in the model is easily obtained and outputted to a SAS dataset using 
the "OE" option in the proc statement. The MLEs are used to calculate the predicted values of 
the outcome at every measured time point for the subjects in the fifth set (the set excluded during 
model building process).  
 The MLE for the intercept and slope of each group (?̂?𝛽0𝑘𝑘 and ?̂?𝛽1𝑘𝑘, respectively) are used to 
calculate ?̂?𝜇𝑖𝑖𝑖𝑖𝑘𝑘, the MLE of the expected value of the repeated measures outcome, 𝑌𝑌𝑖𝑖𝑖𝑖𝑘𝑘: 
?̂?𝜇𝑖𝑖𝑖𝑖𝑘𝑘 = ?̂?𝛽0𝑘𝑘 + ?̂?𝛽1𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖 + ?̂?𝛽2𝑘𝑘𝑡𝑡𝑖𝑖𝑡𝑡𝑒𝑒𝑖𝑖𝑖𝑖2 . 
The MLE of 𝜃𝜃 = (𝜃𝜃1, … , 𝜃𝜃𝑘𝑘) and 𝛾𝛾 = (𝛾𝛾1, … , 𝛾𝛾𝑘𝑘), denoted as 𝜃𝜃� = �𝜃𝜃�1, … ,𝜃𝜃�𝑘𝑘� and 𝛾𝛾� =(𝛾𝛾�1, … , 𝛾𝛾�𝑘𝑘), are also available in the SAS dataset using the "OE" option. These MLEs are used to 
find an estimate of the posterior probability of group membership: 
𝜋𝜋�𝑖𝑖
𝑘𝑘 = 𝑃𝑃�𝑃𝑃(𝐶𝐶𝑖𝑖 = 𝑘𝑘|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖) = 𝑒𝑒𝑒𝑒𝑒𝑒�𝜃𝜃�𝑘𝑘 + 𝛾𝛾�𝑘𝑘′ 𝑧𝑧𝑖𝑖�∑ 𝑒𝑒𝑒𝑒𝑒𝑒�𝜃𝜃�𝑙𝑙 + 𝛾𝛾�𝑙𝑙′𝑧𝑧𝑖𝑖�𝐾𝐾𝑙𝑙=1 , 
Proc TRAJ does not provide the MLE for 𝜃𝜃1 and 𝛾𝛾1 because these values are always zero. 
Therefore, the estimate for the posterior probability of being in group one simplifies to: 
𝜋𝜋�𝑖𝑖
1 = 𝑃𝑃�𝑃𝑃(𝐶𝐶𝑖𝑖 = 1|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖) = 11 + ∑ 𝑒𝑒𝑒𝑒𝑒𝑒�𝜃𝜃�𝑙𝑙 + 𝛾𝛾�𝑙𝑙′𝑧𝑧𝑖𝑖�𝐾𝐾𝑙𝑙=2 , 
and an estimate of the posterior probability for all other latent subgroups is calculated by : 
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𝜋𝜋�𝑖𝑖
𝑘𝑘 = 𝑃𝑃�𝑃𝑃(𝐶𝐶𝑖𝑖 = 𝑘𝑘|𝑍𝑍𝑖𝑖 = 𝑧𝑧𝑖𝑖) = 𝑒𝑒𝑒𝑒𝑒𝑒�𝜃𝜃�𝑘𝑘 + 𝛾𝛾�𝑘𝑘′ 𝑧𝑧𝑖𝑖�1 + ∑ 𝑒𝑒𝑒𝑒𝑒𝑒�𝜃𝜃�𝑙𝑙 + 𝛾𝛾�𝑙𝑙′𝑧𝑧𝑖𝑖�𝐾𝐾𝑙𝑙=2 , 
where 𝑘𝑘 = 2, … ,𝐾𝐾. 
 Once the MLE for the posterior probability of group membership and the MLE of the 
expected value of 𝑌𝑌𝑖𝑖𝑖𝑖𝑘𝑘 are calculated, an estimate of the mean of 𝑌𝑌𝑖𝑖𝑖𝑖 can be calculated for each 
subject as a weighted average: 
𝑦𝑦�𝑖𝑖𝑖𝑖
[−𝑤𝑤] = �𝜋𝜋�𝑖𝑖𝑘𝑘?̂?𝜇𝑖𝑖𝑖𝑖𝑘𝑘𝐾𝐾
𝑘𝑘=1
. 
The estimate of the mean of the repeated measures outcome, 𝑌𝑌𝑖𝑖𝑖𝑖, also known as the predicted 
values, are then compared to the actual measurements of 𝑌𝑌𝑖𝑖𝑖𝑖 for each subject in the fifth set. In 
this thesis we compare the predicted values to the observed values using absolute deviation 
(AD): 
𝐴𝐴𝐷𝐷𝑤𝑤𝑖𝑖𝑖𝑖 = �𝑦𝑦𝑖𝑖𝑖𝑖 − 𝑦𝑦�𝑖𝑖𝑖𝑖[−𝑤𝑤]�. 
 Once the absolute deviation is calculated at every time point for each subject the average across 
all time points for each individual 𝑖𝑖 is calculated: 
𝐴𝐴𝐷𝐷𝑤𝑤𝑖𝑖 = 1𝐽𝐽𝑖𝑖�𝐴𝐴𝐷𝐷𝑤𝑤𝑖𝑖𝑖𝑖𝐽𝐽𝑖𝑖
𝑖𝑖=1
. 
Lastly, the grand mean AD across all subjects is calculated: 
𝐴𝐴𝐷𝐷𝑤𝑤 = 1𝑁𝑁�𝐴𝐴𝐷𝐷𝑤𝑤𝑖𝑖𝑁𝑁
𝑖𝑖=1
 
This process is then repeated for each step of five-fold CV (Figure 1), where at each iteration a 
new set is held out for validation, resulting in five values of AD. The average AD across each set 
is calculated as: 
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𝐴𝐴𝐷𝐷 = 15 �𝐴𝐴𝐷𝐷𝑤𝑤5
𝑤𝑤=1
. 
Once five-fold CV is completed, the whole process is repeated, where the only thing that differs 
in the models is the number of latent subgroups. The model with the number of latent subgroups 
that results in the smallest AD should be chosen. 
 18 
3.0  CLINICAL APPLICATION 
Prior research in patients with hepatitis C (HCV) found that those who reported poor sleep 
quality preceding the start of treatment were at a higher risk for developing major depressive 
disorder (MDD) than those with good sleep quality [33]. Whether this association holds 
generally among the entire study population or whether it was driven by a specific subgroup is 
currently unknown. Therefore, GBLTM was applied to the HCV study in order to address the 
following two aims: first, to determine whether patterns of change in depressive symptoms 
formed clinically meaningful, distinct subgroups, and second, to test the hypothesis that 
subjectively assessed sleep disturbances are associated with less favorable depression 
trajectories. 
3.1 BACKGROUND OF HEPATITIS C (HCV) STUDY 
3.1.1 Recruitment 
Patients with HCV were recruited at a University of Pittsburgh Medical Center that specializes in 
liver diseases prior to starting treatment of pegylated interferon-alpha2 (PEG-IFN-α2a: 135 
μg/week or PEG-IFN-α2b: 120 or 150 μg/week) and oral ribavirin. Those who were 
recommended for interferon-α (IFN-α) treatment by their hepatologist were asked to participate 
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in a research study where they would be followed for up to four months in order to investigate 
the association of INF-α and depression. All subjects provided written informed consent as per 
protocol by the University of Pittsburgh Institutional Review Board. 
3.1.2 Exclusion Criteria 
Subjects were excluded if they had an active Axis-I disorder (e.g. mood, anxiety, psychotic, 
impulse control, or drug/alcohol use disorders) within six months prior to starting treatment 
because the primary interest of the study was to detect interferon-induced depression (IFN-
MDD). An Axis-I disorder was assessed using the Structural Clinical Interview for DSM-IV 
Axis I Disorders (SCID-I) [34]. Subjects were also excluded if they had a history of prior 
depressive episodes where subjects had been in remission for less than six months, known 
neurological disease, known active inflammatory disorders other than HCV, or if they were 
taking medications known to influence the immune system (e.g. corticosteroids, anticonvulsants, 
and/or antipsychotics). 
3.1.3 Patient Characteristics 
There were 124 patients diagnosed with HCV who began IFN-α therapy. Patients were mostly 
male (64.5% (n=80)) and Caucasian (90.3% (n=112)) with a mean (standard deviation) age of 
45.7 (12.3) years. Other than HCV, subjects had medical burden that was comparable to those in 
their 40s without HCV, based on the Cumulative Illness Rating Scale-Geriatric [35]. Subjects 
who developed major mood disorder during treatment were given a psychiatric intervention, 
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consisting of an antidepressant or mood stabilizing medication, and their subsequent data was 
censored. 
3.1.4 Variables of Interest 
The amount of depressive symptoms a subject had was measured prior to starting treatment and 
at weeks 2, 4, 8, 12, and 16 during treatment using the Beck Depression Inventory-II (BDI) [36]. 
The BDI consists of 21 questions where an individual can score 0-3 on each, resulting in a total 
range of 0-63. Scores on the BDI are categorized as minimal depression (0-13), mild depression 
(14-19), moderate depression (20-28), and severe depression (29-63). Subjects who scored a 15 
or higher on the BDI during the course of treatment were administered an abbreviated SCID-I in 
order to detect a DSM-IV mood disorder.  
Self-reported sleep quality was assessed prior to starting treatment using the Pittsburgh 
Sleep Quality Index (PSQI) [37]. The PSQI ranges from 0-21, where a higher score means worse 
sleep quality. A score below five on the PSQI typically indicates no problem with sleep and 
scores of five or higher indicate some sleep problems, where the median PSQI score of subjects 
diagnosed with insomnia is ten [37-39]. In order to account for sleep as a potential risk factor, 
BDI minus the sleep item (BDI-s) was used in analyses. 
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4.0  MODEL SELECTION USING BIC 
4.1 DETERMINING THE NUMBER OF SUBGROUPS 
The model selection process used in GBLTM is already well established using the Bayesian 
Information Criterion (BIC) [19, 23]. Examining the overall trajectories of depressive symptoms 
during the course of treatment it is clear that the HCV sample does not follow one single pattern 
(Figure 2). The number of latent subgroups of depressive symptoms over time was determined 
by examining the BIC. Five different models were considered, where each model consisted of a 
different number of latent subgroups; up to six latent subgroups were considered. A model with 
more than six groups was not considered because these models failed to converge. Each of the 
five models were examined by using first-degree polynomials and then again by using second-
degree polynomials. A first-degree polynomial indicates that the trajectory is assumed to be a 
straight line. Similarly, a second-degree polynomial means that the trajectory is assumed to be a 
quadratic curve. When determining the optimal number of distinct subgroups in model selection, 
it is suggested that setting a second-degree polynomial for all trajectories is best because a 
quadratic form is very flexible in its ability to capture different rates of change [23]. Although, 
for completeness and because most of our data follows a linear pattern, a first-degree polynomial 
was examined as well.  
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Figure 2. Individual trajectories of BDI-s prior to starting treatment and during 
treatment 
 
In section 2.1.1, it is explained that the largest BIC is best, as long as it is a meaningful 
difference in BIC between the models that are being compared. Figure 3 displays the BIC for the 
five models with two to six subgroups when applying all linear terms and when applying all 
quadratic terms. The BIC increases monotonically until it reaches a six-group model, with more 
substantive increases occurring between groups two and three. After group three the slope of 
change in BIC decreases, but it is still apparent that the model is doing better up to a five-group 
solution. When comparing two models, the null model (or the simpler model) is the model with 
the smaller number of subgroups. Thus, when comparing a three-group to a two-group model, 
the null model would be the two-group model, and the log Bayes factor approximation is a way 
to judge the amount of evidence against the simpler model. In Table 2, each model was 
compared to the model that had one less subgroup. According to the criteria for the log Bayes 
factor approximation (Table 1) there exists “very strong” evidence against every null model 
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except when comparing a six-group model to a five-group model. The six-group model failed to 
converge when all trajectories were set to a quadratic curve, furthering the evidence against a 
six-group model. Thus, it appears that five groups is the optimal number of latent subgroups to 
describe the HCV sample. 
 
Table 2. Determining the number of subgroups using BIC 
 
Number of  
Latent Subgroups 
Number of 
groups in the 
Null Model 
All Linear Terms All Quadratic Terms 
BIC 2(∆BIC) BIC 2(∆BIC) 
2  -1526.2  -1526.1  
3 2 -1489.5 73.4 -1491.8 68.6 
4 3 -1482.1 14.8 -1485.3 13.2 
5 4 -1473.5 17.3 -1474.7 21.2 
6 5 -1478.8 -10.6 ------ ------ 
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Figure 3. BIC for models with two through five subgroups 
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4.2 DETERMINING THE BEST POLYNOMIAL DEGREE FOR EACH 
TRAJECTORY 
The next step is to determine the polynomial degree for each trajectory in the five-group model. 
This is done by examining every permutation of linear and quadratic terms, resulting in thirty-
two five-group models examined (Table 3). For simplicity, BIC in Table 3 was sorted from best 
to worst, and then labeled model one to thirty-two. The difference between BIC for each model 
is illustrated in Figure 4, where it is apparent that model one is consistently the best. Whether or 
not the decline in BIC after model one is significant was again examined using the log Bayes 
factor approximation.  
Every model was compared to model one and because model one contains mostly linear 
terms, it is the null model for every comparison except with model sixteen, which has all linear 
terms. The log Bayes factor approximation is negative for every comparison (except for model 
sixteen) indicating that there is no evidence against the null model: model one. When comparing 
model one to sixteen, there is “very strong” evidence against the null model: model sixteen. 
Therefore, model one was chosen as the best combination of polynomial degrees for a five-group 
model. 
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Table 3. Determining the best polynomial degree for each trajectory in a five-group model 
using BIC 
 
Model Polynomial degree BIC 
2loge(B10) 
≈2*(∆BIC) 
1 1 1 1 1 2 -1466.4   
2 1 2 1 1 2 -1467.8 -2.8 
3 1 1 2 1 2 -1468.6 -4.2 
4 1 1 1 2 2 -1468.8 -4.7 
5 2 1 1 1 2 -1468.9 -4.8 
6 1 2 2 1 2 -1470.0 -7.0 
7 1 2 1 2 2 -1470.2 -7.5 
8 2 2 1 1 2 -1470.3 -7.6 
9 1 1 2 2 2 -1470.9 -8.9 
10 2 1 2 1 2 -1471.0 -9.0 
11 2 1 1 2 2 -1471.2 -9.5 
12 1 2 2 2 2 -1472.3 -11.7 
13 2 2 2 1 2 -1472.4 -11.8 
14 2 2 1 2 2 -1472.6 -12.3 
15 2 1 2 2 2 -1473.3 -13.7 
16 1 1 1 1 1 -1473.5 14.0 
17 2 2 2 2 2 -1474.7 -16.5 
18 1 1 2 1 1 -1474.8 -16.7 
19 1 2 1 1 1 -1474.8 -16.7 
20 1 1 1 2 1 -1475.8 -18.7 
21 2 1 1 1 1 -1475.9 -18.8 
22 1 2 2 1 1 -1476.4 -20.0 
23 1 2 1 2 1 -1477.1 -21.4 
24 2 2 1 1 1 -1477.2 -21.6 
25 1 1 2 2 1 -1477.4 -21.8 
26 2 1 2 1 1 -1477.5 -22.1 
27 2 1 1 2 1 -1478.2 -23.5 
28 1 2 2 2 1 -1478.7 -24.5 
29 2 2 2 1 1 -1478.9 -24.8 
30 2 2 1 2 1 -1479.5 -26.2 
31 2 1 2 2 1 -1479.8 -26.7 
32 2 2 2 2 1 -1481.1 -29.3 
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Figure 4. Determining the best polynomial degree for each trajectory in a five-group 
model using BIC 
4.3 ADDING RISK FACTORS TO THE BEST-FIT MODEL 
After the optimal number of groups and the best-fit polynomial degree for each group is 
determined, risk factors can be added. PSQI was added to the best-fit five-group model as a 
potential risk factor in order to answer the hypothesis of interest. When adding risk factors in 
Proc TRAJ it is advised to use well-informed start values [17], which help the program locate the 
true MLEs. Start values are the MLE of the intercept and slope for each trajectory group, the 
MLE of the variance, and the MLE of theta in the posterior probability. All start values are 
obtained from running the model with no risk factors. The program outputs the values to the log, 
which can then copied and pasted in the Proc TRAJ code with risk factors using the “start” 
statement. A MLE for the risk factors also have to be specified, so if you have a five-group 
model four start values have to be listed for each risk factor added. However, the start values for 
the risk factors are not outputted in the log, so it is suggested to use zero for their values.  
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When adding in the start values in addition to PSQI as a potential risk factor to the best-
fit five-group model, the model runs with no convergence issues. The average and predicted 
group trajectories are illustrated in Figure 5. Groups one and two are very similar, both groups on 
average have very low depressive symptoms prior to starting treatment and these low symptoms 
remain, on average, constant during the course of treatment. Together, these two groups make up 
about 38% of the HCV sample. Group three makes up about 30% of the sample, and on average 
also experiences consistently low depressive symptoms that are slightly higher than groups one 
and two, but are still relatively and persistently mild during the course of treatment. The fourth 
group is made up of about 24% of the sample; on average, they experienced minimal depression 
prior to starting treatment, but steadily increase to moderate depression by four months of IFN-α. 
The fifth group consists of a small subgroup of the sample, about 8%. They experienced mild 
depression on average prior to starting treatment and rapidly increase to severe depression just 
after one month on IFN-α. All subjects in the fifth group were diagnosed with a mood disorder 
and were excluded from the study by three months of IFN-α because they needed antidepressant 
treatment.  
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Figure 5. Best-fit five-group model of BDI-s prior to starting treatment and during 
treatment when including PSQI at a baseline risk factor 
4.4 BIC SUGGESTING TOO MANY GROUPS 
When considering the average group intercept and slope of change in Figure 5 it appears that 
there exist a smaller number of distinct latent subgroups in the HCV sample. Investigating the 
individual trajectories by each of the five groups (Figure 6), it appears that groups one, two, and 
some individuals from group three could be combined to one group. Each individual’s trajectory 
in group one and two do not differ by much. Some subjects in group three also appear to have a 
consistently low trajectory as well. Group four appears to consist of a few subjects that could be 
combined to group five, and the majority of group four could be combined with some subjects in 
group three, to get a better representation of a group that has a steady increase in their depressive 
symptoms over the course of treatment. These observations are consistent with other studies [1-
29 
6], which suggests BIC indicates a larger number of groups than what is needed to describe the 
data in a meaningful and parsimonious fashion. 
When PSQI is added as a baseline risk factor along with the start values from the best-fit 
model with no risk factors included, the observed and predicted trajectories differ (Figure 5 
compared with Figure 14 in Appendix A). Groups two, three, and four are altered with addition 
of a baseline risk factor, the slope of one of the trajectory groups even changes direction. The 
addition of a baseline risk factor should not alter a model this immensely; therefore furthering 
the evidence against the five-group model. 
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Figure 6. Individual trajectories of BDI-s prior to starting treatment and during 
treatment by the best-fit five group model when including PSQI as a baseline risk 
factor 
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5.0  CROSS-VALIDATION RESULTS 
The GBLTM analysis on the sample of 124 patients treated for HCV is validated using three 
types of CV: n-fold CV, five-fold CV, and five by two-fold CV. Table 4 displays the overall 
mean absolute deviation (AD) between observed and predicted values of BDI-s for two through 
five latent subgroups for each of these types of CV. Six latent groups were not included, due to 
convergence issues reported in section 4.1. The results are split up into two sections: setting all 
trajectories to a linear curve and setting all trajectories to a quadratic curve.  
CV was consistently a more conservative approach to determining the optimal number of 
latent subgroups (compared with BIC). All three types of CV suggest that a two-group model 
results in the smallest error (Table 4, Figure 7). The AD steadily increases as the number of 
latent subgroups increases. Although, the increase in AD is very small: there is a 9% relative 
increase in AD for a three-group model compared to a two-group model, a 6% relative increase 
in AD for a four-group model compared to a three-group model, and a 4% relative increase in 
AD for a five-group model compared to a four-group model. 
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Table 4. Absolute Deviation between observed and predicted values of BDI-s for different 
number of latent subgroups using cross-validation 
 
Polynomial 
Degree for 
each group 
Number 
of Latent 
Classes 
AD 
n-fold 
CV 
5-fold 
CV 
5x2-fold 
CV 
First-degree 
2 6.603 6.583 6.592 
3 7.206 7.202 7.210 
4 7.639 7.640 7.640 
5 7.950 7.943 7.965 
Second-degree 
2 6.603 6.583 6.601 
3 7.232 7.238 7.241 
4 7.692 7.693 7.688 
5 7.988 7.994 8.159 
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Figure 7. Absolute Deviation between observed and predicted values of BDI-s for different 
number of latent subgroups using cross-validation 
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5.1 INVESTIGATING THE TRUE NUMBER OF LATENT SUBGROUPS 
CV suggests a two-group model, whereas BIC suggests a five-group model, but when visually 
inspecting the data, a three-group model appears to best illustrate the distinct subgroups in the 
sample. A four-group model is very similar to the three-group model, adding in what appears to 
be a redundant non-distinct group (Figure 8 and 9 compared with Figure 10 and 11). A portion of 
the individuals that make up the second group of the four-group model could be combined with 
the first group and the others that have a larger increasing slope could be combined with the third 
group. A few individuals with a large increase in depressive symptoms in the third group could 
be combined to the fourth group. Thus, concluding a three-group model appears better than a 
four-group model.  
When examining a two-group model, there is a group of subjects that experience low 
average depressive symptom prior to starting treatment that has a slight overall increase during 
treatment and another group that starts off with a higher overall average depressive symptom 
count, that is steadily increasing at a slightly higher rate of change compared with the first group, 
but decreases around the last time point (Figure 12). The decrease in the trajectory of the second 
group is occurring because the individuals who are rapidly becoming depressed are excluded 
before the end of the study (Figure 13). This can cause a misinterpretation of the second group 
because it appears that overall the subjects are eventually becoming less depressed around 16 
weeks of treatment, when in fact the opposite is true. The second group is also very 
heterogeneous, where there is not one overall pattern of the group (Figure 13), similar to what 
was found when examining the overall plot of individual trajectories of depressive symptoms for 
every subject (Figure 2). Thus, it still remains apparent that the three-group model appears to be 
best capturing all information in the HCV sample in the most parsimonious way. 
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Figure 8. Best-fit four-group model of BDI-s prior to starting treatment and during 
treatment when including PSQI as a baseline risk factor 
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Figure 9. Individual trajectories of BDI-s prior to starting treatment and during treatment 
by the best-fit four-group model when including PSQI as a baseline risk factor 
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Figure 10. Best-fit three-group model of BDI-s prior to starting treatment and during 
treatment when including PSQI at a baseline risk factor 
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Figure 11. Individual trajectories of BDI-s prior to starting treatment and during 
treatment by the best-fit three-group model when including PSQI as a baseline risk 
factor 
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Figure 12. Best-fit two-group model of BDI-s prior to starting treatment and during 
treatment when including PSQI at a baseline risk factor 
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Figure 13. Individual trajectories of BDI-s prior to starting treatment and during 
treatment by the best-fit two-group model when including PSQI as a baseline risk 
factor 
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6.0  RESULTS OF A THREE-GROUP MODEL 
In the best-fit three-group model, the three groups were labeled as group 1: “non-depressed”, 
group 2: “slow increase”, and group 3: “rapid increase” (Figure 10). The non-depressed and slow 
increase trajectories were best approximated as a linear increase, whereas a quadratic increase was 
best for the rapid increase trajectory. The non-depressed group contained 43.1% (N=54) of the 
sample who started out with a low overall group mean BDI-s of 3.01 at baseline and experienced 
very little change over the course of treatment (Table 5). The slow increasers were made up of 
47.8% (N=59) of the sample and started out with an overall group mean BDI-s of 9.77 which 
steadily increased throughout the course of treatment to mild depression by week 12 of IFN-α 
treatment (14.01). The rapid increasers consisted of 9.1% (N=11) of subjects, with a mean BDI-s 
at baseline categorized as mild depression (15.13), which reached severe depression (34.23), on 
average, after 8 weeks of IFN-α treatment. All rapid increasers were excluded from the study by 
16 weeks of IF     N-α because they began antidepressant treatment. 
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Table 5. Mean and confidence intervals of BDI-s over time by subgroups while adjusting 
for baseline PSQI 
Non-depressed 
N=54 
Mean (95% CI) 
Slow Increase 
N=59 
Mean (95% CI) 
Rapid Increase 
N=11 
Mean (95% CI) 
Pre IFN-α Baseline 3.01 (2.4, 4.9) 9.77 (8.5, 11.5) 15.13 (11.9, 18.3) 
During IFN-α 
Treatment 
Week 2 3.57 (2.6, 4.9) 9.74 (9.2, 11.9) 24.02 (20.2, 24.9) 
Month 1 3.76 (2.7, 4.9) 12.26 (9.9, 12.4) 26.77 (24.8, 30.4) 
Month 2 3.98 (2.8, 5.2) 12.38 (11.1, 13.6) 34.34 (28.6, 38.4) 
Month 3 4.09 (2.7, 5.7) 14.01 (11.9, 15.1) 32.06 (29.3, 38.4) 
Month 4 3.40 (2.3, 6.6) 13.55 (12.8, 17.0) ------ 
Age and sex were not associated with group membership; therefore excluding them from 
the three-group model reported did not drastically alter the results. PSQI significantly predicted 
group membership (Table 6), where worse sleep was associated with a less favorable trajectory. 
With one unit increase in PSQI, the odds of having a slow increase in depressive symptoms 
instead of no change (non-depressed group) increases by 31% and the odds of having a rapid 
increase in depressive symptoms compared to no change increases by 56%. With one unit 
increase in PSQI, the odds of having a rapid increase in depressive symptoms instead of a slow 
increase increases by 19%. The average posterior probability for each group in the model was 
greater than 0.9, thus concluding an adequate model fit. 
Table 6. Baseline PSQI as a risk factor of group membership 
Reference Group: Non-depressed 
Group Variable Estimate (SE), p-value Odds Ratio 
Slow Increase Constant -1.58 (0.51), p=0.002 ---- PSQI 0.272 (0.08), p<0.001 1.31 
Rapid Increase Constant -4.91 (1.1), p<0.001 ---- PSQI 0.448 (0.11), p=0.001 1.56 
Reference Group: Slow Increase 
Group Variable Estimate (SE) Odds 
Rapid Increase Constant -3.33 (1.0), p=0.001 ---- PSQI 0.176 (0.09), p=0.05 1.19 
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7.0  DISCUSSION 
CV was applied to GBLTM for censored normal models as an alternative method to BIC for 
model selection. All three types of CV (n-fold CV, five-fold CV, and five by two-fold CV) 
consistently indicated a two-group solution resulted in the smallest AD between observed and 
predicted values, whereas BIC suggested that a five-group model was best. Therefore, when 
compared with BIC, CV is a more conservative approach to model selection in GBLTM for the 
HCV sample.  
Model selection with BIC in GBLTM is a complex process with many iterations of re-
fitting the model. It appears that there is no one metric to use in the model selection process. 
Visually examining the groups from selected best-fit models can provide judgment on whether 
the model (BIC or CV suggests) is actually fully capturing the distinct latent subgroups of the 
sample. Spaghetti plots are a very useful tool for depicting distinct groups in a sample. As shown 
above, once we plotted the individual trajectories for each subject by the best-fit five-group 
model, it was clear that the data actually followed a three-group model.  
However, BIC and CV should always be considered when determining the optimal 
number of latent subgroups in a model. Both tools for model selection enable the user to make an 
educated judgment regarding the number of latent subgroups in their sample. CV may be more 
useful than BIC in situations where users may want the smallest number of latent subgroups 
possible to describe the heterogeneity in their data. In this case they would be best served with 
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CV as the model selection metric of choice. On the other hand, BIC may be more useful when 
clinically distinct subgroups are continuously identified.  
With an increasing use of GBLTM, there is a greater need for more standardized, 
quantitative, and rigorous methods for selecting the number of latent subgroups in a population. 
This thesis contributes to public health research by exploring different statistical tools used for 
determining the optimal number of latent subgroups in GBLTM. We assessed CV as an 
alternative tool to BIC for model selection in GBLTM and found it is a conservative approach 
compared with BIC for our sample. CV may be more useful to researchers when they are 
interested in selecting the smallest number of groups to explain differences in their target patient 
population and time course. 
7.1 LIMITATIONS 
Whether or not CV is truly a more conservative approach to model selection compared with 
BIC is still unknown. This may be true for only this sample of HCV subjects. CV and BIC 
should be examined using other datasets, as well as using simulations. Another limitation of our 
study is that the five-group model becomes very unstable once a baseline risk factor is 
added, causing a change in the five trajectories. The addition of baseline risk factors 
should not significantly alter the trajectories, indicating that the five-group model without 
baseline risk factors might be displaying distinct subgroups of the HCV population, but 
needs to be determined using a larger sample of patients. 
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7.2 FUTURE WORK 
In our data, CV is a conservative approach to model selection in GBLTM when compared with 
BIC. Although, future work using various simulations can shed light on the generalizability of 
our findings. One simulation should create data that consists of a various number of actual 
trajectory groups to examine whether BIC and/or CV correctly classifies the true groups. 
Another simulation should create data that consists of no distinct groups to examine how BIC 
and CV react. 
 With regard to CV specifically, a meaningful difference in AD between two models is 
unknown. A useful criterion to determine a meaningful difference in AD is needed to examine 
whether the different models are truly differing in their predictability. In also appears that the 
criterion for a meaningful difference in BIC between two models is very lenient. One possibility 
is to manipulate the equation for BIC so that there is a larger penalty term when used in 
GBLTM. An interpretation similar to scree plots could be useful to BIC as well. With scree 
plots, one chooses the first value where the measurements start to level off. For BIC, this would 
mean choosing the number of latent subgroups where the BIC starts to level off, even if the 
addition of a latent group represents a meaningful difference in the BIC according to the log 
Bayes factor approximation. Using this interpretation, a three-group model would be suggested 
for the HCV sample (Figure 3). 
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8.0  CONCLUSION 
CV offers a conservative approach to model selection in GBLTM when compared with BIC. 
However, both BIC and CV should be used with caution during model selection in GBLTM. A 
visual inspection of the data should always be performed before concluding which model is the 
best-fit. Overall group mean observed and predicted values should be plotted and inspected as 
well as the overall and by group spaghetti plots. Examining these plots can give researchers an 
idea regarding whether or not the large number of latent subgroups suggested by BIC are 
actually distinct subgroups in the sample.  
Examining solutions suggested by CV, along with the associated plots gives one insight 
on whether or not a small number of groups is picking up on all of the information shown in the 
data. Missing data should also be inspected as with every repeated measures analysis. When 
plotting overall group mean observed and predicted values, if a group that experiences a less 
favorable trajectory is suddenly on average doing better at the end of the study, carefully 
examine the data to see if this is simply due to drop out towards the end of the study. The 
subjects that are having a worse experience are more likely to drop out of the study, thus making 
the trajectory appear as if the group gets better towards the last few visits. BIC, CV, and an 
educated judgment are useful tools for model selection when determining the optimal number of 
latent subgroups in a sample using GBLTM. 
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APPENDIX A: BEST-FIT MODELS WITHOUT BASELINE RISK FACTORS 
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Figure 14. Best-fit five-group model without baseline risk factors 
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Figure 15. Best-fit four-group model without baseline risk factors 
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Figure 16. Best-fit three-group model without baseline risk factors 
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Figure 17. Best-fit two-group model without baseline risk factors 
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APPENDIX B: CROSS-VALIDATION SAS MACROS 
B.1 N-FOLD CV 
%macro nfold(datafile=, N=,ngroups=, order=, num_timepts=, y1=, y2=, y3=, y4=, y5=, 
y6=,time1=,time2=,time3=,time4=,time5=,time6=,min=,max=); 
%let outcome1=%upcase(&y1); 
%let outcome2=%upcase(&y2); 
%let outcome3=%upcase(&y3); 
%let outcome4=%upcase(&y4); 
%let outcome5=%upcase(&y5); 
%let outcome6=%upcase(&y6); 
proc sort data=&datafile;by id;run; 
data use; 
set &datafile; 
obs=_N_; 
run; 
data use; 
set use; 
do i =1 to &N; 
delete_obs=0; 
if obs=i then delete_obs=1; 
output; 
end; 
run; 
proc sort data=use;by i;run; 
data use; 
set use; 
if delete_obs=1 then delete; 
run; 
data use; 
set use; 
drop delete_obs; 
rename i=sampling_group; 
run; 
*creating empty dataset to put MLEs in;
data info; 
do sampling_group =1 to &N; 
output; 
end; 
run; 
%DO i=1 %to &N; 
*create separate datasets because proc traj doesnt allow where statement;
data use&i; 
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 set use; 
 where sampling_group=&i; 
run; 
PROC TRAJ DATA=use&i OUTPLOT=OP OUTSTAT=OS OUT=OF OUTEST=OE ITDETAIL; 
    ID ID; VAR &y1 &y2 &y3 &y4 &y5 &y6; INDEP &time1 &time2 &time3 &time4 &time5 
&time6; 
 MODEL CNORM; min &min; MAX &max; ngroups &ngroups; ORDER &order; 
RUN; 
 
*Find MLE of betas: in OE dataset; 
data oe; 
 set oe; 
 where _type_="PARMS"; 
 drop _model_ _model2_ _name_; 
 sampling_group=&i; 
run; 
data info; 
 merge info oe(drop=_type_); 
 by sampling_group; 
run; 
%end; 
 
proc means data=info noprint; 
 var _BIC1_ _BIC2_ _AIC_; 
 output out=bic_means; 
run; 
data bic_means; 
 set bic_means; 
 where _STAT_="MEAN"; 
 rename _BIC1_=avg_BIC1_ _BIC2_=avg_BIC2_ _AIC_=avg_AIC_; 
run; 
 
proc sort data=&datafile;by id;run; 
data use_; 
 set &datafile; 
 sampling_group=_N_; 
run; 
proc sort data=use_;by sampling_group;run; 
proc sort data=info;by sampling_group;run; 
data info; 
 merge use_ info; 
 by sampling_group; 
 theta1=0; 
 sum_exptheta=0; 
 check_pi=0; 
run; 
 
%DO k=1 %to &ngroups; 
data info; 
 set info; 
 sum_exptheta=sum_exptheta+exp(theta&k); 
run; 
%end; 
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%DO k=1 %to &ngroups; 
data info; 
 set info; 
 mu_i_j1_k&k=sum(interc&k,&time1*linear&k,&time1*&time1*QUADRA&k); 
 mu_i_j2_k&k=sum(interc&k,&time2*linear&k,&time2*&time2*QUADRA&k); 
 mu_i_j3_k&k=sum(interc&k,&time3*linear&k,&time3*&time3*QUADRA&k); 
 mu_i_j4_k&k=sum(interc&k,&time4*linear&k,&time4*&time4*QUADRA&k); 
 mu_i_j5_k&k=sum(interc&k,&time5*linear&k,&time5*&time5*QUADRA&k); 
 mu_i_j6_k&k=sum(interc&k,&time6*linear&k,&time6*&time6*QUADRA&k); 
 pi_hat_k&k=exp(theta&k)/sum_exptheta; 
 check_pi=check_pi+pi_hat_k&k; 
run; 
%end; 
 
proc sort data=info;by id;run; 
proc transpose data=info out=info_long; 
 by id; 
run; 
data info_long; 
 set info_long; 
 name=upcase(_name_); 
run; 
 
data true_values; 
 set info_long; 
 where name="&outcome1" | name="&outcome2" | name="&outcome3" | name="&outcome4" 
| name="&outcome5" | name="&outcome6"; 
 rename col1=outcome; 
run; 
 
%DO j=1 %to &num_timepts; 
data true_values; 
 set true_values; 
 if index(name,"&outcome1") ge 1 then time=1; 
 if index(name,"&outcome2") ge 1 then time=2; 
 if index(name,"&outcome3") ge 1 then time=3; 
 if index(name,"&outcome4") ge 1 then time=4; 
 if index(name,"&outcome5") ge 1 then time=5; 
 if index(name,"&outcome6") ge 1 then time=6; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_long; 
 where name contains "MU"; 
  if index(name,"K&k") ge 1; 
 rename col1=mu&k; 
run; 
data info_pik&k; 
 set info_long; 
 where name contains "PI_HAT"; 
  if index(name,"K&k") ge 1; 
 rename col1=pi&k; 
run; 
%end; 
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%DO j=1 %to &num_timepts; 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_muk&k; 
 if index(name,"J&j") ge 1 then time=&j; 
run; 
%end; 
%end; 
 
proc sort data=info_long nodupkeys;by id;run; 
data info_long; 
 set info_long; 
 keep id; 
run; 
 
*creating empty dataset to put MLEs in; 
proc sort data=info_long;by id;run; 
data info_long; 
 SET info_long; 
 do time=1 to &num_timepts; 
 by id; 
 output; 
end; 
run; 
 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id time;run; 
proc sort data=true_values;by id time;run; 
proc sort data=info_muk&k;by id time;run; 
data info_long; 
 merge info_long true_values(keep=id time outcome) info_muk&k(keep=id mu&k 
time); 
 by id time; 
run; 
%end; 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id;run; 
proc sort data=info_pik&k;by id;run; 
data info_long; 
 merge info_long info_pik&k(keep=id pi&k); 
 by id; 
 y_hat_sum=0; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info_long; 
 set info_long; 
 y_hat&k=(pi&k*mu&k); 
 y_hat_sum=sum(y_hat_sum,y_hat&k); 
run; 
%end; 
data info_long; 
 set info_long; 
 yhat=(1/&ngroups)*y_hat_sum; 
 abs_dev=abs(outcome-yhat); 
 MSE=(outcome-yhat)**2; 
run; 
proc means data=info_long noprint; 
 var abs_dev MSE; 
 class id; 
 output out=diff_mean; 
run; 
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data diff_mean; 
 set diff_mean; 
 where _Stat_="MEAN"; 
 if id=. then delete; 
run; 
proc means data=diff_mean noprint; 
 var abs_dev mse; 
 output out=grand_mean; 
run; 
data grand_mean; 
 set grand_mean; 
 where _Stat_="MEAN"; 
run; 
 
*what BIC gives you for all available data;  
PROC TRAJ DATA=&datafile OUTPLOT=OP OUTSTAT=OS OUT=OF OUTEST=OE ITDETAIL; 
    ID ID; VAR &y1 &y2 &y3 &y4 &y5 &y6; INDEP &time1 &time2 &time3 &time4 &time5 
&time6; 
 MODEL CNORM; min &min; MAX &max; ngroups &ngroups; ORDER &order; 
RUN; 
data oe_full; 
 set oe; 
 where _type_="PARMS"; 
 keep _type_ _LOGLIK_--_AIC_; 
 rename _LOGLIK_=LOGLIK_full_model _BIC1_=BIC1_full_model _BIC2_=BIC2_full_model 
_AIC_=AIC_full_model; 
run; 
 
data info_yhat; 
 merge grand_mean(keep=abs_dev mse) oe_full(drop=_type_) 
bic_means(keep=avg_BIC1_  
avg_BIC2_ avg_AIC_); 
 poly_order="&order"; 
 number_of_groups="&ngroups"; 
 label LOGLIK_full_model="Log Likelihood" BIC1_full_model="BIC1"  
  BIC2_full_model="BIC2" AIC_full_model="AIC" 
  number_of_groups="Number of Latent Classes" abs_dev="Absolute deviation  
between obs and pred" MSE="MSE between obs and pred" 
poly_order="Polynomial Degree for each Group" 
avg_BIC1_="Average BIC1 across 5 folds" avg_BIC2_="Average BIC2 across 5 
folds" avg_AIC_="Average AIC across 5 folds"; 
run; 
proc print data=info_yhat noobs label; 
 var number_of_groups poly_order ABS_DEV MSE avg_BIC1_ avg_BIC2_ avg_AIC_ 
BIC1_full_model BIC2_full_model AIC_full_model;  
run; 
 
%mend nfold; 
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 B.2 FIVE-FOLD CV 
%macro fivefold(datafile=, N=, ngroups=, order=, num_timepts=, y1=, y2=, y3=, y4=,  
y5=, y6=,time1=,time2=,time3=,time4=,time5=,time6=,min=,max=); 
 
%let outcome1=%upcase(&y1); 
%let outcome2=%upcase(&y2); 
%let outcome3=%upcase(&y3); 
%let outcome4=%upcase(&y4); 
%let outcome5=%upcase(&y5); 
%let outcome6=%upcase(&y6); 
 
proc sort data=&datafile;by id;run; 
data use; 
 set &datafile; 
 obs=_N_; 
run; 
 
%let rand_samp_size=%eval(&N/5); 
 
*First fold; 
proc surveyselect data=use method=SRS rep=1 
  sampsize=&rand_samp_size seed=12345 out=rand_select1; 
  id _all_; 
run; 
data rand_select1; 
 set rand_select1; 
 delete=1; 
 rand_samp=1; 
run; 
proc sort data=use;by id;run; 
proc sort data=rand_select1;by id;run; 
data round2; 
 merge use rand_select1(keep=id delete); 
 by id; 
run; 
data round2; 
 set round2; 
 where delete NE 1; 
run; 
 
*Second fold; 
proc surveyselect data=round2 method=SRS rep=1 
  sampsize=&rand_samp_size seed=12345 out=rand_select2; 
  id _all_; 
run; 
data rand_select2; 
 set rand_select2; 
 delete=1; 
 rand_samp=2; 
run; 
proc sort data=round2;by id;run; 
proc sort data=rand_select2;by id;run; 
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data round3; 
 merge round2 rand_select2(keep=id delete); 
 by id; 
run; 
data round3; 
 set round3; 
 where delete NE 1; 
run; 
 
*Third fold; 
proc surveyselect data=round3 method=SRS rep=1 
  sampsize=&rand_samp_size seed=12345 out=rand_select3; 
  id _all_; 
run; 
data rand_select3; 
 set rand_select3; 
 delete=1; 
 rand_samp=3; 
run; 
proc sort data=round3;by id;run; 
proc sort data=rand_select3;by id;run; 
data round4; 
 merge round3 rand_select3(keep=id delete); 
 by id; 
run; 
data round4; 
 set round4; 
 where delete NE 1; 
run; 
 
*Fourth fold; 
proc surveyselect data=round4 method=SRS rep=1 
  sampsize=&rand_samp_size seed=12345 out=rand_select4; 
  id _all_; 
run; 
data rand_select4; 
 set rand_select4; 
 delete=1; 
 rand_samp=4; 
run; 
proc sort data=round4;by id;run; 
proc sort data=rand_select4;by id;run; 
data round5; 
 merge round4 rand_select4(keep=id delete); 
 by id; 
run; 
data round5; 
 set round5; 
 where delete NE 1; 
run; 
 
*Fifth fold; 
data round5; 
 set round5; 
 rand_samp=5; 
run; 
proc sort data=use;by id;run; 
proc sort data=rand_select1;by id;run; 
proc sort data=rand_select2;by id;run; 
proc sort data=rand_select3;by id;run; 
proc sort data=rand_select4;by id;run; 
proc sort data=round5;by id;run; 
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data rand_samp; 
 merge use rand_select1(keep=id rand_samp) rand_select2(keep=id rand_samp) 
rand_select3(keep=id rand_samp) 
  rand_select4(keep=id rand_samp) round5(keep=id rand_samp); 
 by id; 
run; 
*check; 
proc freq data=rand_samp; 
 tables rand_samp; 
run; 
 
*creating empty dataset to put MLEs in; 
data info; 
 do rand_samp=1 to 5; 
 output; 
end; 
run; 
 
%DO i=1 %to 5; 
*create separate datasets because proc traj doesnt allow where statement; 
data use_without_&i; 
 set rand_samp; 
 if rand_samp=&i then delete; 
run; 
PROC TRAJ DATA=use_without_&i OUTPLOT=OP OUTSTAT=OS OUT=OF OUTEST=OE ITDETAIL; 
    ID ID; VAR &y1 &y2 &y3 &y4 &y5 &y6; INDEP &time1 &time2 &time3 &time4 &time5 
&time6; 
 MODEL CNORM; min &min; MAX &max; ngroups &ngroups; ORDER &order; 
RUN; 
 
*Find MLE of betas: in OE dataset; 
data oe; 
 set oe; 
 where _type_="PARMS"; 
 drop _model_ _model2_ _name_; 
 rand_samp=&i; 
run; 
data info; 
 merge info oe(drop=_type_); 
 by rand_samp; 
run; 
 
%end; 
 
proc means data=info noprint; 
 var _BIC1_ _BIC2_ _AIC_; 
 output out=bic_means; 
run; 
data bic_means; 
 set bic_means; 
 where _STAT_="MEAN"; 
 rename _BIC1_=avg_BIC1_ _BIC2_=avg_BIC2_ _AIC_=avg_AIC_; 
run; 
 
proc sort data=rand_samp;by rand_samp;run; 
proc sort data=info;by rand_samp;run; 
data info; 
 merge rand_samp info; 
 by rand_samp; 
 theta1=0; 
 sum_exptheta=0; 
 check_pi=0; 
run; 
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%DO k=1 %to &ngroups; 
data info; 
 set info; 
 sum_exptheta=sum_exptheta+exp(theta&k); 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info; 
 set info; 
 mu_i_j1_k&k=sum(interc&k,&time1*linear&k,&time1*&time1*QUADRA&k); 
 mu_i_j2_k&k=sum(interc&k,&time2*linear&k,&time2*&time2*QUADRA&k); 
 mu_i_j3_k&k=sum(interc&k,&time3*linear&k,&time3*&time3*QUADRA&k); 
 mu_i_j4_k&k=sum(interc&k,&time4*linear&k,&time4*&time4*QUADRA&k); 
 mu_i_j5_k&k=sum(interc&k,&time5*linear&k,&time5*&time5*QUADRA&k); 
 mu_i_j6_k&k=sum(interc&k,&time6*linear&k,&time6*&time6*QUADRA&k); 
 pi_hat_k&k=exp(theta&k)/sum_exptheta; 
 check_pi=check_pi+pi_hat_k&k; 
run; 
%end; 
 
proc sort data=info;by id;run; 
proc transpose data=info out=info_long; 
 by id; 
run; 
data info_long; 
 set info_long; 
 name=upcase(_name_); 
run; 
 
data true_values; 
 set info_long; 
 where name="&outcome1" | name="&outcome2" | name="&outcome3" | name="&outcome4" 
| name="&outcome5" | name="&outcome6"; 
 rename col1=outcome; 
run; 
 
%DO j=1 %to &num_timepts; 
data true_values; 
 set true_values; 
 if index(name,"&outcome1") ge 1 then time=1; 
 if index(name,"&outcome2") ge 1 then time=2; 
 if index(name,"&outcome3") ge 1 then time=3; 
 if index(name,"&outcome4") ge 1 then time=4; 
 if index(name,"&outcome5") ge 1 then time=5; 
 if index(name,"&outcome6") ge 1 then time=6; 
run; 
%end; 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_long; 
 where name contains "MU"; 
  if index(name,"K&k") ge 1; 
 rename col1=mu&k; 
run; 
data info_pik&k; 
 set info_long; 
 where name contains "PI_HAT"; 
  if index(name,"K&k") ge 1; 
 rename col1=pi&k; 
run; 
%end; 
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%DO j=1 %to &num_timepts; 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_muk&k; 
 if index(name,"J&j") ge 1 then time=&j; 
run; 
%end; 
%end; 
 
proc sort data=info_long nodupkeys;by id;run; 
data info_long; 
 set info_long; 
 keep id; 
run; 
 
*creating empty dataset to put MLEs in; 
proc sort data=info_long;by id;run; 
data info_long; 
 SET info_long; 
 do time=1 to &num_timepts; 
 by id; 
 output; 
end; 
run; 
 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id time;run; 
proc sort data=true_values;by id time;run; 
proc sort data=info_muk&k;by id time;run; 
data info_long; 
 merge info_long true_values(keep=id time outcome) info_muk&k(keep=id mu&k 
time); 
 by id time; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id;run; 
proc sort data=info_pik&k;by id;run; 
data info_long; 
 merge info_long info_pik&k(keep=id pi&k); 
 by id; 
 y_hat_sum=0; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info_long; 
 set info_long; 
 y_hat&k=(pi&k*mu&k); 
 y_hat_sum=sum(y_hat_sum,y_hat&k); 
run; 
%end; 
 
data info_long; 
 set info_long; 
 yhat=(1/&ngroups)*y_hat_sum; 
 abs_dev=abs(outcome-yhat); 
 MSE=(outcome-yhat)**2; 
run; 
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proc means data=info_long noprint; 
 var abs_dev MSE; 
 class id; 
 output out=diff_mean; 
run; 
data diff_mean; 
 set diff_mean; 
 where _Stat_="MEAN"; 
 if id=. then delete; 
run; 
 
proc means data=diff_mean noprint; 
 var abs_dev mse; 
 output out=grand_mean; 
run; 
data grand_mean; 
 set grand_mean; 
 where _Stat_="MEAN"; 
run; 
 
*what BIC gives you for all available data;  
PROC TRAJ DATA=&datafile OUTPLOT=OP OUTSTAT=OS OUT=OF OUTEST=OE ITDETAIL; 
    ID ID; VAR &y1 &y2 &y3 &y4 &y5 &y6; INDEP &time1 &time2 &time3 &time4 &time5 
&time6; 
 MODEL CNORM; min &min; MAX &max; ngroups &ngroups; ORDER &order; 
RUN; 
data oe_full; 
 set oe; 
 where _type_="PARMS"; 
 keep _type_ _LOGLIK_--_AIC_; 
 rename _LOGLIK_=LOGLIK_full_model _BIC1_=BIC1_full_model _BIC2_=BIC2_full_model 
_AIC_=AIC_full_model; 
run; 
 
data info_yhat; 
 merge grand_mean(keep=abs_dev mse) oe_full(drop=_type_) 
bic_means(keep=avg_BIC1_ avg_BIC2_ avg_AIC_); 
 poly_order="&order"; 
 number_of_groups="&ngroups"; 
 label LOGLIK_full_model="Log Likelihood" BIC1_full_model="BIC1"  
BIC2_full_model="BIC2" AIC_full_model="AIC" 
  number_of_groups="Number of Latent Classes" abs_dev="Absolute deviation  
between obs and pred" MSE="MSE between obs and pred"  
poly_order="Polynomial Degree for each Group" 
  avg_BIC1_="Average BIC1 across 5 folds" avg_BIC2_="Average BIC2 across 5  
folds" avg_AIC_="Average AIC across 5 folds"; 
run; 
proc print data=info_yhat noobs label; 
 var number_of_groups poly_order ABS_DEV MSE avg_BIC1_ avg_BIC2_ avg_AIC_ 
BIC1_full_model BIC2_full_model AIC_full_model;  
run; 
 
%mend fivefold; 
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B.3 FIVE BY TWO-FOLD CV 
%macro fivextwofold(datafile=, seed1=, seed2=, seed3=, seed4=, seed5=, N=, ngroups=, 
order=,num_timepts=,y1=,y2=,y3=,y4=,y5=,y6=,time1=,time2=,time3=,time4=,time5=,time6=,
min=,max=); 
 
%let outcome1=%upcase(&y1); 
%let outcome2=%upcase(&y2); 
%let outcome3=%upcase(&y3); 
%let outcome4=%upcase(&y4); 
%let outcome5=%upcase(&y5); 
%let outcome6=%upcase(&y6); 
 
proc sort data=&datafile;by id;run; 
data use; 
 set &datafile; 
 obs=_N_; 
run; 
 
%let rand_samp_size=%eval(&N/2); 
 
%DO REPEAT_CV=1 %to 5; 
 
*First fold; 
proc surveyselect data=use method=SRS rep=1 
  sampsize=&rand_samp_size seed=&&seed&REPEAT_CV out=rand_select1; 
  id _all_; 
run; 
data rand_select1; 
 set rand_select1; 
 delete=1; 
 rand_samp=1; 
run; 
proc sort data=use;by id;run; 
proc sort data=rand_select1;by id;run; 
data round2; 
 merge use rand_select1(keep=id delete); 
 by id; 
run; 
data round2; 
 set round2; 
 where delete NE 1; 
run; 
 
*Second fold; 
data round2; 
 set round2; 
 rand_samp=2; 
run; 
proc sort data=use;by id;run; 
proc sort data=rand_select1;by id;run; 
proc sort data=round2;by id;run; 
data rand_samp; 
 merge use rand_select1(keep=id rand_samp) round2(keep=id rand_samp); 
 by id; 
run; 
*check; 
proc freq data=rand_samp; 
 tables rand_samp; 
run; 
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*creating empty dataset to put MLEs in; 
data info; 
 do rand_samp=1 to 2; 
 output; 
end; 
run; 
%DO i=1 %to 2; 
*create separate datasets because proc traj doesnt allow where statement; 
data use_without_&i; 
 set rand_samp; 
 if rand_samp=&i then delete; 
run; 
PROC TRAJ DATA=use_without_&i OUTPLOT=OP OUTSTAT=OS OUT=OF OUTEST=OE ITDETAIL; 
    ID ID; VAR &y1 &y2 &y3 &y4 &y5 &y6; INDEP &time1 &time2 &time3 &time4 &time5 
&time6; 
 MODEL CNORM; min &min; MAX &max; ngroups &ngroups; ORDER &order; 
RUN; 
*Find MLE of betas: in OE dataset; 
data oe; 
 set oe; 
 where _type_="PARMS"; 
 drop _model_ _model2_ _name_; 
 rand_samp=&i; 
run; 
data info; 
 merge info oe(drop=_type_); 
 by rand_samp; 
run; 
 
%end; 
proc means data=info; 
 var _BIC1_ _BIC2_ _AIC_; 
 output out=bic_means; 
run; 
data bic_means; 
 set bic_means; 
 where _STAT_="MEAN"; 
 rename _BIC1_=avg_BIC1_ _BIC2_=avg_BIC2_ _AIC_=avg_AIC_; 
run; 
proc sort data=rand_samp;by rand_samp;run; 
proc sort data=info;by rand_samp;run; 
data info; 
 merge rand_samp info; 
 by rand_samp; 
 theta1=0; 
 sum_exptheta=0; 
 check_pi=0; 
run; 
 
%DO k=1 %to &ngroups; 
data info; 
 set info; 
 sum_exptheta=sum_exptheta+exp(theta&k); 
run; 
%end; 
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%DO k=1 %to &ngroups; 
data info; 
 set info; 
 mu_i_j1_k&k=sum(interc&k,&time1*linear&k,&time1*&time1*QUADRA&k); 
 mu_i_j2_k&k=sum(interc&k,&time2*linear&k,&time2*&time2*QUADRA&k); 
 mu_i_j3_k&k=sum(interc&k,&time3*linear&k,&time3*&time3*QUADRA&k); 
 mu_i_j4_k&k=sum(interc&k,&time4*linear&k,&time4*&time4*QUADRA&k); 
 mu_i_j5_k&k=sum(interc&k,&time5*linear&k,&time5*&time5*QUADRA&k); 
 mu_i_j6_k&k=sum(interc&k,&time6*linear&k,&time6*&time6*QUADRA&k); 
 pi_hat_k&k=exp(theta&k)/sum_exptheta; 
 check_pi=check_pi+pi_hat_k&k; 
run; 
%end; 
 
proc sort data=info;by id;run; 
proc transpose data=info out=info_long; 
 by id; 
run; 
data info_long; 
 set info_long; 
 name=upcase(_name_); 
run; 
 
data true_values; 
 set info_long; 
 where name="&outcome1" | name="&outcome2" | name="&outcome3" | name="&outcome4" 
| name="&outcome5" | name="&outcome6"; 
 rename col1=outcome; 
run; 
%DO j=1 %to &num_timepts; 
data true_values; 
 set true_values; 
 if index(name,"&outcome1") ge 1 then time=1; 
 if index(name,"&outcome2") ge 1 then time=2; 
 if index(name,"&outcome3") ge 1 then time=3; 
 if index(name,"&outcome4") ge 1 then time=4; 
 if index(name,"&outcome5") ge 1 then time=5; 
 if index(name,"&outcome6") ge 1 then time=6; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_long; 
 where name contains "MU"; 
  if index(name,"K&k") ge 1; 
 rename col1=mu&k; 
run; 
data info_pik&k; 
 set info_long; 
 where name contains "PI_HAT"; 
  if index(name,"K&k") ge 1; 
 rename col1=pi&k; 
run; 
%end; 
%DO j=1 %to &num_timepts; 
%DO k=1 %to &ngroups; 
data info_muk&k; 
 set info_muk&k; 
 if index(name,"J&j") ge 1 then time=&j; 
run; 
%end; 
%end; 
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proc sort data=info_long nodupkeys;by id;run; 
data info_long; 
 set info_long; 
 keep id; 
run; 
 
*creating empty dataset to put MLEs in; 
proc sort data=info_long;by id;run; 
data info_long; 
 SET info_long; 
 do time=1 to &num_timepts; 
 by id; 
 output; 
end; 
run; 
 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id time;run; 
proc sort data=true_values;by id time;run; 
proc sort data=info_muk&k;by id time;run; 
data info_long; 
 merge info_long true_values(keep=id time outcome) info_muk&k(keep=id mu&k 
time); 
 by id time; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
proc sort data=info_long;by id;run; 
proc sort data=info_pik&k;by id;run; 
data info_long; 
 merge info_long info_pik&k(keep=id pi&k); 
 by id; 
 y_hat_sum=0; 
run; 
%end; 
 
%DO k=1 %to &ngroups; 
data info_long; 
 set info_long; 
 y_hat&k=(pi&k*mu&k); 
 y_hat_sum=sum(y_hat_sum,y_hat&k); 
run; 
%end; 
 
data info_long; 
 set info_long; 
 yhat=(1/&ngroups)*y_hat_sum; 
 abs_dev=abs(outcome-yhat); 
 MSE=(outcome-yhat)**2; 
run; 
proc means data=info_long noprint; 
 var abs_dev MSE; 
 class id; 
 output out=diff_mean; 
run; 
data diff_mean; 
 set diff_mean; 
 where _Stat_="MEAN"; 
 if id=. then delete; 
run; 
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proc means data=diff_mean noprint; 
 var abs_dev mse; 
 output out=grand_mean; 
run; 
data grand_mean; 
 set grand_mean; 
 where _Stat_="MEAN"; 
run; 
 
data info_yhat&REPEAT_CV; 
 merge grand_mean(keep=abs_dev mse) bic_means(keep=avg_BIC1_ avg_BIC2_ 
avg_AIC_); 
 poly_order="&order"; 
 number_of_groups="&ngroups"; 
 round=&REPEAT_CV; 
 label number_of_groups="Number of Latent Classes" abs_dev="Absolute deviation  
between obs and pred" MSE="MSE between obs and pred"  
poly_order="Polynomial Degree for each Group" 
  avg_BIC1_="Average BIC1 across 5 folds" avg_BIC2_="Average BIC2 across 5  
folds" avg_AIC_="Average AIC across 5 folds"; 
run; 
%end; 
 
*creating empty dataset to put info in; 
data info_yhat; 
 do round=1 to 5; 
 output; 
end; 
run; 
 
%do REPEAT_CV=1 %to 5; 
data info_yhat; 
 merge info_yhat info_yhat&REPEAT_CV; 
 by round; 
run; 
%end; 
 
PROC MEANS DATA=INFO_YHAT; 
 var ABS_DEV MSE avg_BIC1_ avg_BIC2_ avg_AIC_; 
run; 
 
%MEND FIVEXTWOFOLD; 
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